日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery and Characterization of a First-in-Class LIV1-TLR7/8 Immunomodulatory Conjugate with Robust Myeloid Activation and Antitumor Activity.

发现并表征了具有强大髓系激活和抗肿瘤活性的首创 LIV1-TLR7/8 免疫调节偶联物

Yamazoe Sayumi, Poudel Yam, Sega Emanuela, Mukhopadhyay Anandaroop, Ramakrishnan Radha, Ukairo Okechukwu, Liu Scot, Akter Rahima, Sadanala Keerthi, Que Kathryn, Cheng Qinqin, Kotapati Srikanth, Deshpande Madhura, Cox Matthew, Chourey Shishir, Gupta Anuradha, Kempson James, Pabbisetty Kumar, Kaspady Mahammed, Bhattasali Debabrata, Yip Shiuhang, Wu Dauh-Rurng, Pookot Deepa, Li Yvonne, Kozhich Alexander, Drexler Dieter, Carl Stephen, Deyanova Ekaterina, Smith Michael, Chan Henry, West Sean, Diong S J, Chang Aram, Florin Lore, Mathur Arvind, Strop Pavel, Zapf Christoph W, Law Deborah, Wilson Nicholas, Broz Miranda, Chekler Eugene P

A Meta-Analysis of Patient-Reported Outcomes of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Previously Treated HR+/HER- mBC Using Two Phase 3 (TROPiCS-02 and EVER-132-002) Trials

一项基于两项 3 期(TROPiCS-02 和 EVER-132-002)试验的荟萃分析,比较了 Sacituzumab Govitecan 与医生选择治疗方案在既往接受过治疗的 HR+/HER- mBC 患者中的疗效。

Rugo, Hope S; Xu, Binghe; Dasgupta, Anandaroop; Kaushik, Ankita; Verret, Wendy; Singh, Barinder

Efficacy of sacituzumab govitecan versus treatment of physician's choice in previously treated HR+ and HER2- mBC: a meta-analysis of TROPiCS-02 and EVER-132-002 trials

在既往接受过治疗的 HR+ 和 HER2- 转移性乳腺癌患者中,sacituzumab govitecan 与医生选择的治疗方案相比的疗效:TROPiCS-02 和 EVER-132-002 试验的荟萃分析

Gluz, Oleg; Xu, Binghe; Nanda, Rita; Dasgupta, Anandaroop; Kaushik, Ankita; Verret, Wendy; Sharma, Akanksha; Singh, Barinder; Rugo, Hope S

Q-TWiST Analysis of Sacituzumab Govitecan vs. Chemotherapy in Previously Treated Patients with HR+/HER2- Metastatic Breast Cancer

对既往接受过治疗的 HR+/HER2- 转移性乳腺癌患者进行 Sacituzumab Govitecan 与化疗的 Q-TWiST 分析

Rugo, Hope S; Bardia, Aditya; Schmid, Peter; Tolaney, Sara M; Dasgupta, Anandaroop; Kaushik, Ankita; Verret, Wendy; Gosset, Marine; Brufsky, Adam; Cortés, Javier; Marmé, Frederik

Sacituzumab govitecan in HR(+)HER2(-) metastatic breast cancer: the randomized phase 3 EVER-132-002 trial

Sacituzumab govitecan 治疗 HR(+)HER2(-) 转移性乳腺癌:随机 3 期 EVER-132-002 试验

Xu, Binghe; Wang, Shusen; Yan, Min; Sohn, Joohyuk; Li, Wei; Tang, Jinhai; Wang, Xiaojia; Wang, Ying; Im, Seock-Ah; Jiang, Dongdong; Valdez, Theresa; Dasgupta, Anandaroop; Zhang, Yiran; Yan, Yilin; Komatsubara, Kimberly M; Chung, Wei-Pang; Ma, Fei; Dai, Ming-Shen

Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in the United States, Europe, and Japan

转移性非小细胞肺癌铂类双药化疗联合免疫治疗的真实世界治疗模式和临床结果:美国、欧洲和日本的多区域病例回顾

Leal, Ticiana A; Dasgupta, Anandaroop; Latremouille-Viau, Dominick; Rossi, Carmine; Rai, Pragya; Barlesi, Fabrice; Liu, Stephen V

Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity

通过肿瘤内电穿孔导入CXCL9质粒扩增CXCR3/CXCL9轴,可与IL-12质粒疗法协同作用,诱导强大的抗肿瘤免疫反应。

Lee, Jack Y; Nguyen, Bianca; Mukhopadhyay, Anandaroop; Han, Mia; Zhang, Jun; Gujar, Ravindra; Salazar, Jon; Hermiz, Reneta; Svenson, Lauren; Browning, Erica; Lyerly, H Kim; Canton, David A; Fisher, Daniel; Daud, Adil; Algazi, Alain; Skitzki, Joseph; Twitty, Christopher G

Role of interatrial conduction in atrial fibrillation: Mechanistic insights from renewal theory-based fibrillatory dynamic analysis

心房间传导在心房颤动中的作用:基于更新理论的颤动动力学分析的机制性见解

Quah, Jing Xian; Jenkins, Evan; Dharmaprani, Dhani; Tiver, Kathryn; Smith, Corey; Hecker, Teresa; Joseph, Majo X; Selvanayagam, Joseph B; Tung, Matthew; Stanton, Tony; Ahmad, Waheed; Stoyanov, Nik; Lahiri, Anandaroop; Chahadi, Fahd; Singleton, Cameron; Ganesan, Anand

Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study : Treatment pattern and outcomes in patients with multiple myeloma

未接受自体干细胞移植的新诊断多发性骨髓瘤患者的治疗模式和预后:一项真实世界观察性研究:多发性骨髓瘤患者的治疗模式和预后

He, Jianming; Schmerold, Luke; Van Rampelbergh, Rian; Qiu, Lugui; Potluri, Ravi; Dasgupta, Anandaroop; Li, Lin; Li, Yunan; Hu, Peter; Nemat, Sepideh; Smugar, Steven S; Zeltzer, Paul; Appiani, Carlos; Li, Qing; Mehra, Maneesha; Richarz, Ute

Reconceptualising Atrial Fibrillation Using Renewal Theory: A Novel Approach to the Assessment of Atrial Fibrillation Dynamics

运用更新理论重新定义心房颤动:一种评估心房颤动动力学的新方法

Quah, Jing Xian; Dharmaprani, Dhani; Lahiri, Anandaroop; Tiver, Kathryn; Ganesan, Anand N